Concerns about planned deregulation backed by new research
9 November 2023 / Two recent scientific studies have reported surprising effects caused by CRISPR/Cas gene scissors applications in plants. The new findings are also important for the risk assessment of plants obtained from new genetic engineering (New GE, also known as new genomic techniques, NGT), and increase concerns about EU plans for deregulation.
27 October 2023 / A new publication in the science journal ‘Frontiers in Bioengineering and Biotechnology’ comprehensively reviews unintended genetic changes in plants caused by new genetic engineering processes (or new genomic techniques, NGT). The study shows that the risks associated with NGT plants are frequently underestimated.
Testbiotech filed legal cases against EU Commission decisions
18 October 2023 / The General Court of the European Union today rejected two lawsuits against import approvals awarded to Bayer (T-605/21-8 and T-606/21-8) for genetically engineered plants. Testbiotech filed two legal cases against decisions made by the EU Commission to issue market approvals for genetically engineered soybeans and maize. According to Testbiotech, the risks associated with these transgenic plants have not been assessed as required by law.
Public activity started against deregulation of new genetic engineering (New GE)
13 October 2023 / Currently, all organisms obtained from genetic engineering (New GE) processes in the EU have to undergo risk assessment before they can be released, cultivated or marketed as food. However, strong pressure from the biotech lobby has resulted in the EU Commission wanting to abandon this basic principle in relation to plants obtained from New GE (also called new genomic techniques, NGT). Testbiotech is warning of the possible negative consequences for health, the environment, nature and the livelihoods of future generations.